Herpes simplex virus type 1/adeno-associated virus hybrid vectors

Gene Therapy and Regulation

Volumn 2, Issue 1, 2003, Pages 7-28

  Fraefel, Cornel ^a   Heister, Thomas ^a   Ackermann, Mathias ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adeno associated virus; Herpes simplex virus type 1; HSV AAV hybrid vector; Long term gene expression; Site specific integration

Indexed keywords

COMPLEMENTARY DNA; DNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; LIFE CYCLE; NONHUMAN; REP GENE; REVIEW; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS GENE; VIRUS GENOME; VIRUS HYBRID; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HERPES; HUMAN HERPESVIRUS 1;

EID: 0037224523     PISSN: 13889532     EISSN: None     Source Type: Journal    
DOI: 10.1163/156855803762295404     Document Type: Review

References (108)

1. Balague, C., Kalla, M. and Zhang, W.W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol., 71: 3299-3306.
2. Berns, K.I. (1996). Parvoviridae: the viruses and their replication. In: Fields Virology, Fields, B.N., Knipe, D.M. and Howley, P.M. (Eds.), Lippincott-Raven, Philadelphia, Pa., Vol. 3, pp. 2173-2197.
3. Berns, K.I., Linden, R.M. (1995). The cryptic life style of adeno-associated virus. Bioessays, 17: 237-245.
4. Boviatsis, E.J., Park, J.S., Sena-Esteves, M., Kramm, C.M., Chase, M., Efird, J.T., Wei, M.X., Breakefield, X.O. and Chiocca, E.A. (1994a). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res., 54: 5745-5751.
5. Boviatsis, E.J., Scharf, J.M., Chase, M., Harrington, K., Kowall, N.W., Breakefield, X.O. and Chiocca, E.A. (1994b). Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Ther., 1: 323-331.
6. Cai, W., Gu, B. and Person, S. (1988). Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol., 62: 2596-2604.
7. Campadelli-Fiume, G., Stirpe, D., Boscaro, A., Avitabile, E., Foa-Tomasi, L., Barker, D. and Roizman, B. (1990). Glycoprotein C dependent attachment of herpes simplex virus to susceptible cells leading to productive infection. Virology, 178: 213-222.
8. Coffin, R.S., MacLean, A.R., Latchman, D.S. and Brown, S.M. (1996). Gene delivery to the central and peripheral nervous systems of mice using HSV 1 ICP34.5 deletion mutant vectors. Gene Ther., 3: 886-891.
9. Conway, J.E., Rhys, C.M., Zolotukhin, I., Zolotukhin, S., Muzyczka, N., Hayward, G.S. and Byrne, B.J. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther., 6: 986-993.
10. Costantini, L.C., Jacoby, D.R., Wang, S., Fraefel, C., Breakefield, X.O. and Isacson, O. (1999). Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther., 10: 2481-2494.
11. Deiss, L.P., Chou, J. and Frenkel, N. (1986). Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus. J. Virol., 59: 605-618.
12. Desai, P.G., Schaffer, P.A. and Minson, A.C. (1988). Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J. Gen. Virol., 69: 1147-1156.
13. During, M.J., Naegele, J.R., O'Malley, K.L. and Geller, A.I. (1994). Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science, 266: 1399-1403.
14. Dyall, J. and Bems, K.I. (1998). Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J. Virol., 72: 6195-6198.
15. Feudner, E., de Alwis, M., Thrasher, A.J., Ali, R.R. and Fauser, S. (2001). Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system. J. Virol. Methods, 96: 97-105.
16. Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. and Minson, T. (1992). Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol., 66: 341-348.
17. Fraefel, C., Song, S., Lim, F., Lang, P., Yu, L., Wang, Y., Wild, P. and Geller, A.I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol., 70: 7190-7197.
18. Fraefel, C., Jacoby, D.R., Lage, C., Hilderbrand, H., Chou, J.Y., Alt, F.W., Breakefield, X.O. and Majzoub, J.A. (1997). Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med., 3: 813-825.
19. Geller, A.I. and Breakefield, X.O. (1988). A defective HSV-1 vector expresses Escherichia coli betagalactosidase in cultured peripheral neurons. Science, 241: 1667-1669.
20. Geller, A.I., Keyomarski, K., Bryan, J. and Pardee, A.B. (1990). An efficient deletion mutant packaging system for defective HSV-1 vectors; potential applications to neuronal physiology and human gene therapy. Proc. Natl. Acad. Sci. USA, 87: 8950-8954.
21. Geraghty, R.J., Krummenacher, C., Cohen, G.H., Eisenberg, R.J. and Spear, P.G. (1998). Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science, 280: 1618-1620.
22. Giraud, C., Winocour, E. and Bems, K.I. (1994). Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. USA, 91: 10039-10043.
23. Giraud, C., Winocour, E. and Berns, K.I. (1995). Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol., 69: 6917-6924.
24. Glorioso, J.C. and Fink, D.J. (2002). Use of HSV vectors to modify the nervous system. Curr. Opin. Drug Discov. Devel., 5: 289-295.
25. Goss, J.R., Goins, W.F., Lacomis, D., Mata, M., Glorioso, J.C. and Fink, D.J. (2002). Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes, 51: 2227-2232.
26. Grimm, D., Kern, A., Rittner, K. and Kleinschmidt, J.A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther., 9: 2745-2760.
27. Heilbronn, R. Weller, S.K. and zur Hausen, H. (1990). Herpes simplex virus type 1 mutants for the origin-binding protein induce DNA amplification in the absence of viral replication. Virology, 179: 478-481.
28. Heister, T., Heid, I., Ackermann, M. and Fraefel, C. (2002). Herpes Simplex Virus Type 1/Adeno Associated Virus Hybrid Vectors Mediate Site-Specific Integration at the Adeno-Associated Virus Preintegration Site, AAVS1, on Human Chromosome 19. J. Virol. 76: 7163-7173.
29. Herold, B.C., WuDunn, D., Soltys, N. and Spear, P.G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol., 65: 1090-1098.
30. Herrlinger, U., Woiciechowski, C., Sena-Esteves, M., Aboody, K.S., Jacobs, A.H., Rainov, N.G., Snyder, E.Y. and Breakefield, X.O. (2000). Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol. Ther., 1: 347-357.
31. Ho, D.Y., Saydam, T.C., Fink, S.L., Lawrence, M.S. and Sapolsky, R.M. (1995). Defective herpes virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. J. Neurochem., 65: 842-850.
32. Hocknell, P.K., Wiley, R.D., Wang, X., Evans, T.G., Bowers, W.J., Hanke, T., Federoff, H.J. and Dewhurst, S. (2002). Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J. Virol., 76: 5565-5580.
33. Horsburgh, B.C., Hubinette, M.M., Qiang, D.M., MacDonald, L. and Tufaro, F. (1999). Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther., 6: 922-930.
34. Jacob, R.J. and Roizman, B. (1977). Anatomy of herpes simplex virus DNA. VIII. Properties of the replicating DNA. J. Virol., 23: 394-411.
35. Johnson, P.A., Miyanohara, A., Levine, F., Cahill, T. and Friedman, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol., 66: 2952-2965.
36. Johnston, K.M., Jacoby, D., Pechan, P.A., Fraefel, C., Borghesani, P., Schuback, D., Dunn, R.J., Smith, F.I. and Breakefield, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther., 8: 359-370.
37. Kaludov, N., Brown, K.E., Walters, R.W., Zabner, J. and Chiorini, J.A. (2001). Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol., 75: 6884-6893.
38. Kotin, R.M., Siniscalco, M., Samulski, R.J., Zhu, X.D., Hunter, L., Laughlin, C.A., McLaughlin, S., Muzyczka, N., Rocchi, M. and Bems, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 87: 2211-2215.
39. Kotin, R.M., Linden, R.M. and Bems, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J., 11: 5071-5078.
40. Laquerre, S., Argnani, R., Anderson, D.B., Zucchini, S., Manservigi, R. and Glorioso, J.C. (1998). Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol., 72: 6119-6130.
41. Laughlin, C.A., Tratschin, J.-D., Coon, H. and Carter, B.J. (1983). Cloning of infectious adenoassociated virus genomes in bacterial plasmids. Gene, 23: 65-73.
42. Ligas, M.W. and Johnson, D.C. (1988). A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol., 62: 1486-1494.
43. Lim, F., Hartley, D., Starr, P., Lang, P., Song, S., Yu, L., Wang, Y. and Geller, A.I. (1996). Generation of high-titer defective HSV-1 vectors using an IE2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques, 20: 458-469.
44. Linden, R.M., Ward, P., Giraud, C., Winocour, E. and Berns, K.I. (1996a). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 93: 11288-11294.
45. Linden, R.M., Winocour, E. and Berns, K.I. (1996b). The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA, 93: 7966-7972.
46. Lockshon, D. and Galloway, D.A. (1986). Cloning and characterization of OriL2, a large palindromic replication origin of herpes simplex virus type 2. J. Virol., 58: 513-521.
47. Logvinoff, C. and Epstein, A.L. (2001). A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus. Hum. Gene Ther., 12: 161-167.
48. Loudon, P.T., Blakeley, D.M., Boursnell, M.E., Day, D.A., Duncan, I.A., Lowden, R.C., McLean, C.S., Martin, G., Miller, J.C. and Shaw, M.L. (2001). Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients. J. Gene Med., 3: 458-467.
49. Lusby, E., Fife, K.H. and Berns, K.I. (1980). Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J. Virol., 34: 402-409.
50. Lycke, E., Johansson, M., Svennerholm, B. and Lindahl, U. (1991). Binding of herpes simplex virus to cellular heparan sulfate, an initial step in the adsorption process. J. Gen. Virol., 72: 1131-1137.
51. Markert, J.M., Parker, J.N., Gillespie, G.Y. and Whitley, R.J. (2001). Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes, 8: 17-22.
52. Marshall, E. (2002). Clinical research: Gene therapy a suspect in leukemia-like disease. Science, 298: 34-35.
53. Maul, G.G., Ishov, A.M. and Everett, R.D. (1996). Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology, 217: 67-75.
54. McCarthy, A.M., McMahan, L. and Schaffer, P.A. (1989). Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol., 63: 18-27.
55. McGeoch, D.J., Dalrymple, M.A., Davison, A.J., Dolan, A., Frame, M.C., McNab, D., Perry, L.J., Scott, J.E. and Taylor, P. (1988). The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol., 69: 1531-1574.
56. Montgomery, R.I., Warner, M.S., Lum, B.J. and Spear, P.G. (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell, 87: 427-436.
57. Natsume, A., Matam, M., Wolfe, D., Oligino, T., Goss, J., Huang, S., Glorioso, J. and Fink, D.J. (2002). Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J. Neurotrauma, 19: 61-68.
58. Owens, R.A. (2002). Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1. Curr. Gene Ther., 2: 145-159.
59. Palombo, F., Monciotti, A., Recchia, A., Cortese, R., Ciliberto, G. and La Monica, N. (1998). Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol., 72: 5025-5034.
60. Pawlik, T.M., Nakamura, H., Mullen, J.T., Kasuya, H., Yoon, S.S., Chandrasekhar, S., Chiocca, E.A. and Tanabe, K.K. (2002). Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene. Cancer, 95: 1171-1181.
61. Persichetti, F., Trettel, F., Huang, C.C., Fraefel, C., Timmers, H.T., Gusella, J.F. and MacDonald, M.E. (1999). Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment. Neurobiol. Dis., 6: 364-375.
62. Philpott, N.J., Giraud-Wali, C., Dupuis, C., Gomos, J., Hamilton, H., Berns, K.I. and Falck-Pedersen, E. (2002a). Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J. Virol., 76: 5411-5421.
63. Philpott, N.J., Gomos, J., Berns, K.I. and Falck-Pedersen, E. (2002b). A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. USA, 99: 12381-12385.
64. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V. and Srivastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nature Med., 5: 71-77.
65. Recchia, A., Parks, R.J., Lamartina, S., Toniatti, C., Pieroni, L., Palombo, F., Ciliberto, G., Graham, F.L., Cortese, R., La Monica, N. and Colloca, S. (1999). Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA, 96: 2615-2620.
66. Rees, R.C., McArdle, S., Mian, S., Li, G., Ahmad, M., Parkinson, R. and Ali, S.A. (2002). Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer. Curr. Opin. Mol. Ther., 4: 49-53.
67. Rizzuto, G., Gorgoni, B., Cappelletti, M., Lazzaro, D., Gloaguen, I., Poli, V., Sgura, A., Cimini, D., Ciliberto, G., Cortese, R., Fattori, E. and La Monica, N. (1999). Development of animal models for adeno-associated virus site-specific integration. J. Virol., 73: 2517-2526.
68. Rock, D.L., Nesburn, A.B., Ghiasi, H., Ong, J., Llewis, T.L., Lokensgard, J.R. and Wechsler, S.L. (1987). Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol., 62: 3820-3826.
69. Roizman, B. and Sears, A.E. (1996). Herpes simplex viruses and their replication. In: Fields Virology, Fields, B.N., Knipe, D.M. and Howley, P.M. (Eds.), Lippincott-Raven, Philadelphia, Pa., Vol. 2 (3rd edition), pp. 2231-2295.
70. Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E.A., Tobler, K., Ackermann, M., Breakefield, X.O. and Fraefel, C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther., 9: 2787-2794.
71. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X.O. and Chiocca, E.A. (2001). Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther., 3: 591-601.
72. Samaniego, L.A., Neiderhiser, L. and DeLuca, N.A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol., 72: 3307-3320.
73. Samulski, R.J., Berns, K.I., Tan, M. and Muzyczka, N. (1982). Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA, 79: 2077-2081.
74. Samulski, R.J., Srivastava, A., Bems, K.I. and Muzyczka, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell, 33: 135-143.
75. Samulski, R.J., Zhu, X., Xiao, X., Brook, J.D., Housman, D.E., Epstein, N. and Hunter, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J., 10: 3941-3950.
76. Severini, A., Scraba, D.G. and Tyrrell, D.L. (1996). Branched structures in the intracellular DNA of herpes simplex virus type 1. J. Virol., 70: 3169-3175.
77. Shieh, M.-T., WuDunn, D., Montgomery, R.I., Esko, J.D. and Spear, P.G. (1992). Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol., 116: 1273-1281.
78. Sodeik, B., Ebersold, M.W. and Helenius, A. (1997). Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol., 136: 1007-1021.
79. Sourvinos, G. and Everett, R. (2002). Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells. EMBO J., 21: 4989-4997.
80. Spaete, R.R. and Frenkel, N. (1982). The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell, 30: 295-304.
81. Srivastava, A., Lusby, E.W. and Berns, K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol., 45: 555-564.
82. Stavropoulos, T.A. and Strathdee, C.A. (1998). An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol. 72: 7137-7143.
83. Steven, A.C. and Spear, P.G. (1997). Herpesvirus capsid assembly and envelopment. In: Structural Biology of Viruses, Chiu, W., Burnett, R. and Garcea, R. (Eds.), Oxford University Press, New York, pp. 312-351.
84. Stevens, J.G. (1975). Latent herpes simplex virus and the nervous system. Curt: Top. Microbiol. Immunol., 70: 31-50.
85. Stow, N.D. (1982). Localization of an origin of DNA replication in the TRs/IRs repeated region of the herpes simplex virus type 1 genome. EMBO J., 1: 863-867.
86. Summerford, C. and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteo-glycan is a receptor for adeno-associated virus type 2 virions. J. Virol., 72: 1438-1445.
87. Summerford, C., Bartlett, J.S. and Samulski, R.J. (1999). AlphaVb5 integrin: a co-receptor for adenoassociated virus type 2 infection. Nature Med., 5: 78-81.
88. Summerford, C., Bartlett, J.S. and Samulski, R.J. (2000). Adeno-associated viral vectors and successful gene therapy, the gap is closing. Gene Therapy & Regulation, 1: 9-32.
89. Surosky, R.T., Urabe, M., Godwin, S.G., McQuiston, S.A., Kurtzman, G.J., Ozawa, K. and Natsoulis, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol., 71: 7951-7959.
90. Terry-Allison, T., Montgomery, R.I., Whitbeck, C., Xu, R., Cohen, G.H., Eisenberg, R.J. and Spear, P.G. (1998). HveA (Herpesvirus Entry Mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J. Virol., 72: 5802-5810.
91. Thomson, B.J., Efstathiou, S. and Honess, R.W. (1991). Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature, 351: 78-80.
92. Thomson B.J., Weindler, F.W., Gray, D., Schwaab, V. and Heilbronn, R. (1994). Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression, Virology, 204: 304-311.
93. Urcelay, E., Ward, P., Wiener, S.M., Safer, B. and Kotin, R.M. (1995). Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol., 69: 2038-2046.
94. Vlazny, D.A., Kwong, A. and Frenkel, N. (1982). Site specific cleavage-packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA. Proc. Natl. Acad. Sci. USA, 79: 1423-1427.
95. Wade-Martins, R., Smith, E.R., Tyminski, E., Chiocca, E.A. and Saeki, Y. (2001). An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat. Biotechnol., 19: 1067-1070.
96. Wagner, J.A., Nepomuceno, I.B., Messner, A.H., Moran, M.L., Batson, E.P., Dimiceli, S., Brown, B.W., Desch, J.K., Norbash, A.M., Conrad, C.K., Guggino, W.B., Flotte, T.R., Wine, J.J., Carter, B.J., Reynolds, T.C., Moss, R.B. and Gardner, P. (2002). A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies. Hum. Gene Ther., 13: 1349-1359.
97. Wang, Y., Fraefel, C., Protasi, F., Moore, R.A., Fessenden, J.D., Pessah, I.N., DiFrancesco, A., Breakefield, X. and Allen, P.D. (2000). HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes. Am. J. Physiol. Cell Physiol., 278: C619-C626.
98. Wang, Y., Mukherjee, S., Fraefel, C., Breakefield, X.O. and Allen, P.D. (2002a). Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum. Gene Ther., 13: 261-273.
99. Wang, Y., Camp, S.M., Niwano, M., Shen, X., Bakowska, J.C., Breakefield, X.O. and Allen, P.D. (2002b). Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J. Virol., 76: 7150-7162.
100. Weitzman, M.D., Kyostio, S.R., Kotin, R.M. and Owens, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA, 91: 5808-5812.
101. Weitzman, M.D., Fisher, K.J. and Wilson, J.M. (1996). Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol., 70: 1845-1854.
102. Xiao, X., Li, J. and Samulski, R.J. (1998). Production of hight titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol., 72: 2224-2232.
103. Young, S.M., Jr., McCarty, D.M., Degtyareva, N. and Samulski, R.J. (2000). Roles of adenoassociated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol., 74: 3953-3966.
104. Young, S.M., Jr. and Samulski, R.J. (2001). Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. USA, 98: 13525-13530.
105. Zhang, H.G., Wang, Y.M., Xie, J.F., Liang, X., Hsu, H.C., Zhang, X., Douglas, J., Curiel, D.T. and Mountz, J.D. (2001). Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Gene Ther., 8: 704-712.
106. Zhang, X., Efstathiou, S. and Simmons, A. (1994). Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies. Virology, 202: 530-539.
107. Zhou, X. and Muzyczka, N. (1998). In vitro packaging of adeno-associated virus DNA. J. Virol., 72: 3241-3247.
108. Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T.J., Chiodo, V.A., Phillipsberg, T., Muzyczka, N., Hauswirth, W.W., Flotte, T.R., Byme, B.J. and Snyder, R.O. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods, 28: 158-167.